What is the current Gadobutrol market size?

The Gadobutrol market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Gadobutrol market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Gadobutrol market?

Increasing demand for contrast agents and advancements in medical imaging technology are key drivers.

What are the major challenges facing the Gadobutrol market?

Stringent regulatory requirements and high development costs are significant challenges.

Which regions are leading the Gadobutrol market?

North America and Europe are currently the leading regions, with Asia-Pacific emerging as a growth hub.

Who are the top companies in the Gadobutrol market?

Bayer, GE Healthcare, and Guerbet are among the top companies, with a strong presence globally.

What future opportunities exist in the Gadobutrol market?

Emerging economies and growing demand for diagnostic imaging procedures present significant future opportunities.

How is technology impacting the Gadobutrol market?

Advances in MRI and CT scan technologies are driving the demand for Gadobutrol, enhancing diagnostic capabilities.

What is the current regulatory landscape for the Gadobutrol market?

The market is subject to strict regulations, with the FDA and EMA playing key roles in approving new products.

How will the Gadobutrol market evolve in the next 5 years?

The market will experience steady growth, driven by increasing adoption of diagnostic imaging procedures and technological advancements.

Gadobutrol - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Gadobutrol by Application (Adults, Children), by Types (Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL), Pharmacy Bulk Packages (30 mL and 65 mL)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gadobutrol Market Overview

The Gadobutrol market refers to the global industry involved in the development, manufacturing, and distribution of Gadobutrol, a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) procedures. As a crucial component in the medical imaging sector, the Gadobutrol market size is anticipated to experience significant growth, driven by an increasing demand for diagnostic imaging services. The growth outlook for the Gadobutrol market is positive, with a market forecast that indicates a substantial expansion of the industry over the forecast period. The industry expansion is expected to be driven by advancements in medical technology, an aging population, and an increase in the prevalence of chronic diseases.

Loading chart…

The current Gadobutrol market size is approximately $1.4 billion. The market is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033, driven by macro drivers such as an aging population, an increase in the prevalence of chronic diseases, and advancements in medical technology. Key forces shaping the industry include technology shifts towards more efficient and effective contrast agents, regulations governing the use of contrast agents, and consumer behavior driven by an increasing demand for diagnostic imaging services. The largest region for the Gadobutrol market is North America, while the fastest-growing region is expected to be the Asia-Pacific region.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer HealthCare Pharmaceuticals; SWAPNROOP DRUGS & PHARMACEUTICALS; Manus Aktteva Biopharma; Jilin Tely Imp & Exp; JinYan Chemicals (ShangHai); BOC Sciences; LGM Pharma; Advanced Technology & Industrail; MedKoo Biosciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gadobutrol market is experiencing significant growth, driven by various factors. The market dynamics are shaped by several key elements that impact the Gadobutrol market size and growth forecast.

Growth Drivers2 items

Increasing demand for contrast agents in medical imaging procedures, particularly in magnetic resonance imaging (MRI) and computed tomography (CT) scans, is driving the adoption of Gadobutrol.

Advances in technology, such as the development of high-field MRI machines, are enhancing the diagnostic capabilities of Gadobutrol, leading to increased usage and contributing to the Gadobutrol market growth.

Restraints2 items

Stringent regulatory requirements and approval processes for new contrast agents, including Gadobutrol, can limit market growth by restricting the entry of new products and increasing development costs.

Concerns over nephrogenic systemic fibrosis (NSF) associated with the use of certain contrast agents, including Gadobutrol, may impact prescribing habits and hinder market expansion.

Opportunities2 items

The growing geriatric population and increasing prevalence of chronic diseases are expected to drive demand for medical imaging procedures, creating opportunities for the Gadobutrol market to expand.

Emerging economies with improving healthcare infrastructure and rising healthcare expenditure offer new avenues for growth, as these markets increasingly adopt advanced medical imaging technologies and contrast agents like Gadobutrol.

Challenges2 items

Intense competition in the Gadobutrol market from established players and generic versions of contrast agents can lead to pricing pressures and reduced profit margins for manufacturers.

The need for continuous innovation and investment in research and development to improve the safety and efficacy of Gadobutrol and stay ahead of competitors poses a significant challenge for market participants.

Market Segmentation

Loading chart…

The Gadobutrol market can be segmented based on Application, which includes subtypes such as magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). The application segment contributes significantly to the overall Gadobutrol market size, with MRI being the dominant subtype. This is due to the increasing demand for contrast agents in MRI procedures, particularly in the diagnosis of neurological and vascular disorders. Gadobutrol segmentation is crucial in understanding the market dynamics and identifying opportunities for growth.

The Types segment of the Gadobutrol market includes subtypes such as gadobutrol injection and gadobutrol powder for injection. The types segment is an essential aspect of the market, as it determines the formulation and administration of the contrast agent. The gadobutrol injection subtype accounts for the majority of the market share, owing to its ease of administration and widespread adoption in medical imaging procedures. Understanding the market taxonomy of Gadobutrol is vital in analyzing the competitive landscape and identifying trends in the market.

Gadobutrol Segmentation Breakdown6 items

Application

Adults

Children

Types

Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)

Pharmacy Bulk Packages (30 mL and 65 mL)

Regional Insights

Loading chart…

The Gadobutrol market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of Gadobutrol in medical imaging procedures, favorable policies supporting healthcare infrastructure development, and significant investments in research and development.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include policies supporting medical research, a skilled workforce, and a well-developed ecosystem. Asia Pacific is driven by investments in healthcare, a large and growing population, and increasing adoption of advanced medical technologies. Latin America and Middle East & Africa are expected to experience growth due to improving infrastructure, increasing adoption of medical imaging technologies, and government policies supporting healthcare development.

The regional forecast indicates that Asia Pacific will drive the Gadobutrol market growth in the coming years, with a growing ecosystem and increasing investments in medical research and development. As the global Gadobutrol market continues to evolve, understanding the unique drivers and trends in each region will be crucial for stakeholders to make informed decisions and capitalize on emerging opportunities.

Competitive Landscape

The Gadobutrol market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Gadobutrol competitive landscape is characterized by key competitive levers including regulatory approvals, certifications, and partnerships. Global players tend to dominate the market, but local companies are also gaining traction through targeted strategies.

Companies in the Gadobutrol market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, and product launches. Common differentiation factors include technology, service model, and channel strength. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can impact their ability to compete effectively. To stay ahead, companies must focus on strategic initiatives that drive growth and profitability.

Bayer HealthCare Pharmaceuticals: regional expansion

SWAPNROOP DRUGS & PHARMACEUTICALS: vertical integration

Manus Aktteva Biopharma: premium pricing

Jilin Tely Imp & Exp: OEM tie-ups

JinYan Chemicals (ShangHai): innovation pipeline

BOC Sciences: local manufacturing

Key Gadobutrol Companies9 items

Bayer HealthCare Pharmaceuticals

SWAPNROOP DRUGS & PHARMACEUTICALS

Manus Aktteva Biopharma

Jilin Tely Imp & Exp

JinYan Chemicals (ShangHai)

BOC Sciences

LGM Pharma

Advanced Technology & Industrail

MedKoo Biosciences

Market Ecosystem

The Gadobutrol ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of Gadobutrol, a contrast agent used in medical imaging. Understanding the interplay between these stakeholders is crucial for conducting a comprehensive value chain analysis of the Gadobutrol ecosystem.

Raw material suppliers — provide chemical components

OEMs / manufacturers — produce Gadobutrol

Distributors / channel partners — deliver to healthcare facilities

Service providers / after-sales — offer support and maintenance

End users / buyers — healthcare providers and patients

Regulators/standards bodies — oversee safety and efficacy

Data/analytics providers — track usage and outcomes

In the Gadobutrol ecosystem, control points are primarily held by regulators and manufacturers, as they influence adoption through approvals and production capacities. Dependency risks arise from input constraints, such as raw material availability, and standards compliance. Switching costs are relatively high due to the specialized nature of medical imaging equipment and the need for compatibility with existing systems. Partnerships between manufacturers and distributors are critical for ensuring widespread availability, while interoperability requirements can vary by region, affecting the ecosystem's dynamics in different areas.

Recent Industry Insights

The Gadobutrol industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have focused on enhancing distribution networks and expanding the global reach of Gadobutrol-based contrast agents. Notable mergers and acquisitions have also taken place, with major players consolidating their positions in the market. Furthermore, several product launches have introduced innovative formulations and administration methods, improving patient outcomes and diagnostic accuracy.

Additionally, regulatory changes have influenced the competitive landscape of the Gadobutrol market. Shifts in consumer and enterprise trends have driven the demand for more effective and safer contrast agents. Funding rounds and expansions have also been observed, with companies investing in research and development to improve their product portfolios and stay ahead in the market.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Gadobutrol market outlook is promising, driven by increasing demand for contrast agents in medical imaging procedures. The market attractiveness is moderate, with a competitive intensity that is relatively high due to the presence of established players. The long-term outlook is positive, with opportunities for growth in emerging markets and innovation in product development.

The innovation landscape is evolving, with a focus on developing more efficient and safer contrast agents. However, the demand-supply balance is a key risk factor, as fluctuations in supply can impact market dynamics. Overall, the Gadobutrol market is expected to experience steady growth, driven by advances in medical imaging technology and increasing healthcare expenditure.

11 items

1. Executive Summary

2. Gadobutrol Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gadobutrol Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Gadobutrol Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Adults

6.1.2. Children

6.2. Global Gadobutrol Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)

6.2.2. Pharmacy Bulk Packages (30 mL and 65 mL)

6.3. Global Gadobutrol Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Gadobutrol Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gadobutrol Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gadobutrol Market Competition by Key Manufacturers

8.1. Global Gadobutrol Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Gadobutrol: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bayer HealthCare Pharmaceuticals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. SWAPNROOP DRUGS & PHARMACEUTICALS

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Manus Aktteva Biopharma

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Jilin Tely Imp & Exp

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. JinYan Chemicals (ShangHai)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BOC Sciences

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. LGM Pharma

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Advanced Technology & Industrail

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. MedKoo Biosciences

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gadobutrol Market

Figure 4: Global Gadobutrol Market: Drivers

Figure 5: Global Gadobutrol Market: Challenges

Figure 6: Global Gadobutrol Market: Trends

Figure 7: Global Gadobutrol Market: Opportunity

Figure 8: Global Gadobutrol Market: Restraint

Figure 9: Global Gadobutrol Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Gadobutrol Market Value (USD Million) By Region

Figure 15: Global Gadobutrol Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Gadobutrol Market Value (USD Million) By Region

Figure 23: Global Gadobutrol Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Gadobutrol Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gadobutrol Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gadobutrol Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Gadobutrol Market Value (USD Million) By Region

Table 10: Global Gadobutrol Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Gadobutrol Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Gadobutrol Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Gadobutrol Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bayer HealthCare Pharmaceuticals Basic Information And Sales Area

Table 31: Bayer HealthCare Pharmaceuticals. Products Portfolio

Table 32: SWAPNROOP DRUGS & PHARMACEUTICALS Basic Information And Sales Area

Table 33: SWAPNROOP DRUGS & PHARMACEUTICALS. Products Portfolio

Table 34: Manus Aktteva Biopharma Basic Information And Sales Area

Table 35: Manus Aktteva Biopharma. Products Portfolio

Table 36: Jilin Tely Imp & Exp Basic Information And Sales Area

Table 37: Jilin Tely Imp & Exp. Products Portfolio

Table 38: JinYan Chemicals (ShangHai) Basic Information And Sales Area

Table 39: JinYan Chemicals (ShangHai). Products Portfolio

Table 40: BOC Sciences Basic Information And Sales Area

Table 41: BOC Sciences. Products Portfolio

Table 42: LGM Pharma Basic Information And Sales Area

Table 43: LGM Pharma. Products Portfolio

Table 44: Advanced Technology & Industrail Basic Information And Sales Area

Table 45: Advanced Technology & Industrail. Products Portfolio

Table 46: MedKoo Biosciences Basic Information And Sales Area

Table 47: MedKoo Biosciences. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Gadobutrol Market Value (USD Million) By Region

Table 53: Global Gadobutrol Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Gadobutrol Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer HealthCare Pharmaceuticals; SWAPNROOP DRUGS & PHARMACEUTICALS; Manus Aktteva Biopharma; Jilin Tely Imp & Exp; JinYan Chemicals (ShangHai); BOC Sciences; LGM Pharma; Advanced Technology & Industrail; MedKoo Biosciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for contrast agents in medical imaging procedures, particularly in magnetic resonance imaging (MRI) and computed tomography (CT) scans, is driving the adoption of Gadobutrol.

Restraints2 items

Concerns over nephrogenic systemic fibrosis (NSF) associated with the use of certain contrast agents, including Gadobutrol, may impact prescribing habits and hinder market expansion.

Opportunities2 items

Challenges2 items

Intense competition in the Gadobutrol market from established players and generic versions of contrast agents can lead to pricing pressures and reduced profit margins for manufacturers.

Market Segmentation

Loading chart…

Gadobutrol Segmentation Breakdown6 items

Application

Adults

Children

Types

Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)

Pharmacy Bulk Packages (30 mL and 65 mL)

Regional Insights

Loading chart…

Competitive Landscape

Bayer HealthCare Pharmaceuticals: regional expansion

SWAPNROOP DRUGS & PHARMACEUTICALS: vertical integration

Manus Aktteva Biopharma: premium pricing

Jilin Tely Imp & Exp: OEM tie-ups

JinYan Chemicals (ShangHai): innovation pipeline

BOC Sciences: local manufacturing

Key Gadobutrol Companies9 items

Bayer HealthCare Pharmaceuticals

SWAPNROOP DRUGS & PHARMACEUTICALS

Manus Aktteva Biopharma

Jilin Tely Imp & Exp

JinYan Chemicals (ShangHai)

BOC Sciences

LGM Pharma

Advanced Technology & Industrail

MedKoo Biosciences

Market Ecosystem

Raw material suppliers — provide chemical components

OEMs / manufacturers — produce Gadobutrol

Distributors / channel partners — deliver to healthcare facilities

Service providers / after-sales — offer support and maintenance

End users / buyers — healthcare providers and patients

Regulators/standards bodies — oversee safety and efficacy

Data/analytics providers — track usage and outcomes

Recent Industry Insights

Analyst Overview

Table of Contents